Compound Detail
CHEMBL10742
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL10742 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | KHZVLIGYCOKVNA-OGLMXYFKSA-N |
2
Targets
4
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
429.5
MW (Da)
5.44
ALogP
4
HBA
1
HBD
68.1
PSA (Ų)
0.36
QED
1
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 6.19
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Prostacyclin receptor CHEMBL1995 | IC50 | 6.19 | 6.19 | 650.0 | 2 |
| Homo sapiens CHEMBL372 | IC50 | 5.96 | 5.96 | 1100.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Prostacyclin receptor | IC50 | = | 650.0 | nM | 6.19 | Displacement of [3H]iloprost from Prostaglandin I2 receptor of human platelets | - |
| Prostacyclin receptor | IC50 | = | 650.0 | nM | 6.19 | Prostaglandin I2 receptor binding by displacement of [3H]iloprost from human pla... | - |
| Homo sapiens | IC50 | = | 1100.0 | nM | 5.96 | Inhibitory activity against ADP-induced platelet aggregation using human platele... | - |
| Homo sapiens | IC50 | = | 1100.0 | nM | 5.96 | Evaluated for inhibition of 4 uM ADP-induced human platelet aggregation | - |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.1016/0960-894X(95)00168-S | Prostacyclin receptor | 1 |
| - | 10.1016/0960-894X(95)00168-S | Homo sapiens | 1 |
| - | 10.1016/0960-894X(95)00167-R | Prostacyclin receptor | 1 |
| - | 10.1016/0960-894X(95)00167-R | Homo sapiens | 1 |
Data from ChEMBL 36 via Core Engine